Aceto: acquisition of Finar Ltd.
Life-sciences supplier Aceto has acquired a majority stake in Finar Limited, a provider of excipients, lab chemicals and other gear. The move is intended to complement Aceto’s growth strategy, expanding its manufacturing footprint, R&D capabilities, and expertise.
“We are excited to bring together Finar and Aceto to give customers of both companies more solutions to support their supply chains globally,” said Gilles Cottier, CEO of Aceto. “With the Finar team’s help, we continue to strengthen our manufacturing expertise and expand our product offerings for the pharmaceutical, biopharmaceutical, and vaccine end markets.”